In the project initial phase, we demonstrated that CMLD-2 treatment was able to reproduce the effects of HuR silencing in both decreasing the cell viability, by inducing apoptotic processes, and reducing some features of tumor cell aggressiveness. Here, ELAVL1 is linked to neoplasm.